Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single‐Dose Administration in Healthy Japanese and White Adults

Documenti analoghi

• A Phase 1 Randomized Study: Garadacimab Pharmacokinetics, Safety, and Tolerability After Administration via Autoinjector/Pre‐Filled Pen Versus Pre‐Filled Syringe in Healthy Participants
  di: Fiona Glassman, et al.
  Pubblicazione: (2025)
• Intravenous Ganaxolone: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability in Healthy Adults
  di: Maciej Gasior, et al.
  Pubblicazione: (2024)
• Pharmacokinetics, Receptor Occupancy, and Pharmacodynamics of Obexelimab Following Intravenous Administration in Adult Healthy Volunteers and in Patients With Rheumatoid Arthritis
  di: Xiaodong Wang, et al.
  Pubblicazione: (2025)
• Pharmacokinetics and Safety of a Single Subcutaneous or Intramuscular Dose of Ketamine in Healthy Horses
  di: Ana Rangel, et al.
  Pubblicazione: (2025)
• Timing of Onset of Garadacimab for Preventing Hereditary Angioedema Attacks
  di: Petra Staubach, et al.
  Pubblicazione: (2024)